公开(公告)号：US11420970B1

公开(公告)日：2022-08-23

申请号：US17327226

申请日：2021-05-21

申请人： NOVARTIS AG

发明人： Haibing Deng ,  Jinbiao Liu ,  Counde Oyang ,  Ce Wang ,  Qitao Xiao ,  Guoliang Xun ,  Haiqiang Zeng

IPC分类号： C07D473/34

摘要： The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).